What AMD means and why its stage matters
Age-related macular degeneration affects the retinal area responsible for fine central detail. Reading, recognising faces and following a line may become difficult. Early findings can exist without obvious symptoms, and a better-seeing eye may compensate for the other.
Assessment distinguishes early, intermediate and advanced stages. Advanced forms include atrophy and neovascular, often called “wet”, AMD. Ask which stage is present in each eye and which findings require monitoring rather than accepting only that the macula is “ageing”.
Age and family history contribute to risk. Stopping smoking, managing cardiovascular factors with your clinician and maintaining a varied diet are useful measures, but none guarantees prevention. An examination identifies and monitors disease; it is not itself a preventive treatment.
A line becomes wavy: what to do
Contact an ophthalmologist today for new wavy lines, a central patch or disappearing letters. If already under treatment, tell your centre without waiting for the next injection or review. Major sudden loss, blackout or a curtain requires immediate assessment.
OCT shows macular cross sections and helps identify fluid, structural changes or atrophy. Images are interpreted alongside vision and retinal examination. A stable finding can still cause persistent difficulty, but a new symptom requires comparison and reassessment.
If recommended, use an Amsler grid with reading glasses, one eye at a time, looking at the central point. It helps notice changes from your baseline. It does not image the retina and can miss disease. A seemingly normal grid should not delay contact about newly noticed distortion.
AREDS2 supplements: indications and limits
The AREDS2 formulation may reduce progression risk in some people with intermediate AMD or advanced disease in only one eye. It does not restore lost vision and is not general insurance for people without AMD. Even an early AMD diagnosis does not automatically mean supplements are indicated.
Before starting, confirm your stage and discuss medicines and other supplements. High-dose vitamins and minerals can interact with treatment. A product advertised simply as “for the macula” is not necessarily equivalent to the studied formulation.
Older AREDS formulations containing beta-carotene carry a particular risk for current and former smokers. AREDS2 does not contain beta-carotene. Do not choose only by the name on a package; clarify suitable ingredients and continue monitoring even with regular use.

Injections and support for daily activities
In active neovascular AMD, abnormal vessels may leak fluid or blood. The centre considers intravitreal anti-VEGF medicine to control activity and preserve or improve function where possible. Not every established change is reversible.
Injection number and interval depend on response, vision and imaging. Improvement after one treatment does not mean you can stop independently. Ask whom to contact about a new symptom or missed appointment. Increasing pain, marked redness or worse vision after injection requires immediate contact with the centre.
When disease is stable but reading remains difficult, larger type, directed lighting, magnifiers or visual rehabilitation may help. These complement monitoring. Bring a concrete goal, such as reading a message or price label, to choose useful support.
Sources · National Eye Institute — Age-Related Macular Degeneration · National Eye Institute — AREDS2 supplements
All sources and further reading (3)
Illustrative images from the website’s image library.
- AI-generated illustrative image
- AI-generated illustrative image
